Cost-effectiveness of inhaled nitric oxide in near-term and term infants with respiratory failure: Eighteen- to 24-month follow-up for Canadian patients
- 1 October 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 30 (10) , 2330-2334
- https://doi.org/10.1097/00003246-200210000-00023
Abstract
The objective of this article is to conduct a cost-effectiveness analysis, based on data up to 18-24 months of follow-up, of the use of inhaled nitrogen oxide vs. oxygen, administered to near-term and term infants with severe respiratory failure who were referred for consideration for extracorporeal membrane oxygenation. The cost-effectiveness analysis was conducted alongside a randomized controlled trial conducted by the Canadian Inhaled Nitric Oxide Study Group for patients with severe respiratory distress. Patients were cared for in Canadian regional neonatal intensive care units; follow-up treatment was based on standard care. Term and near-term neonates with severe respiratory failure determined by at least two oxygenation indexes (oxygenation index = mean arterial pressure x Fio2/Pao2) >/=25 at least 15 mins apart. Patients were randomized to inhaled nitrogen oxide or oxygen. If conditions deteriorated, they qualified for extracorporeal membrane oxygenation. Not all who qualified received extracorporeal membrane oxygenation. Standard care followed after hospital discharge. Timelines of analysis were from randomization until the follow-up, which occurred between 18 and 24 months after randomization. Costs included those for initial hospitalization (neonatal intensive care, medications, extracorporeal membrane oxygenation, transport) and standard medical services above routine care and developmental services received until follow-up. Outcomes included mortality rate, clinical outcomes, and a variety of neurodevelopmental indicators. Costs were not significantly different between interventions. While infants who received inhaled nitrogen oxide generally did better than those who received oxygen, the only variable that was significant was the number of seizure disorders. On economic grounds, inhaled nitrogen oxide was the preferred intervention.Keywords
This publication has 12 references indexed in Scilit:
- Inhaled nitric oxide in term and near-term infants: Neurodevelopmental follow-up of The Neonatal Inhaled Nitric Oxide Study Group (NINOS)The Journal of Pediatrics, 2000
- A cost-effectiveness analysis of the application of nitric oxide versus oxygen gas for near-term newborns with respiratory failure: Results from a Canadian randomized clinical trialCritical Care Medicine, 2000
- Economic evaluation and randomised controlled trial of extracorporeal membrane oxygenation: UK collaborative trial Commentary: Concurrent economic evaluations are rare but should be standard practiceBMJ, 1998
- Inhaled Nitric Oxide and Hypoxic Respiratory Failure in Infants With Congenital Diaphragmatic HerniaPediatrics, 1997
- Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the NewbornNew England Journal of Medicine, 1997
- Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory FailureNew England Journal of Medicine, 1997
- UK collaborative randomised trial of neonatal extracorporeal membrane oxygenationThe Lancet, 1996
- A Cost-Effectiveness Analysis of Neonatal ECMO Using Existing EvidenceInternational Journal of Technology Assessment in Health Care, 1996
- Extracorporeal Membrane Oxygenation in Term NewbornsAsaio Journal, 1993
- TERM INFANTS WITH HYPOXIC‐ISCHEMIC ENCEPHALOPATHY: OUTCOME AT 3.5 YEARSDevelopmental Medicine and Child Neurology, 1985